Management of atrial fibrillation around the world: A comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines

Europace

Volumn 13, Issue 10, 2011, Pages 1368-1374

  Wasmer, Kristina ^a   Eckardt, Lars ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

(Focused) Update; Atrial fibrillation; Current guidelines; New guidelines

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DABIGATRAN; DIGITALIS; DOFETILIDE; DRONEDARONE; FLECAINIDE; HEPARIN; PROPAFENONE; SOTALOL; VERNAKALANT; WARFARIN;

ANTICOAGULATION; BLEEDING; CATHETER ABLATION; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STROKE; SYMPTOM; THROMBOEMBOLISM; TREATMENT INDICATION;

ATRIAL FIBRILLATION; CANADA; DISEASE MANAGEMENT; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES; WORLD HEALTH;

EID: 79961101164     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur172     Document Type: Review

References (30)

1. European Heart Rhythm Association, European ssociation for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart J 2010;31:2369-429.
2. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NAM III et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline). Heart Rhythm 2011;8:157-76.
3. Wann LS, Curtis AB, Ellenbogen KA, Estes NAM III, Ezekowitz MD, Jackman WM et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). Circulation 2011;123:1144-50.
4. Gillis AM, Skanes AC. CCS Atrial Fibrillation Guideline Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and achieving consensus. Can J Cardiol 2011;27:27-30.
5. Healey JS, Parkash R, Pollak T, Tsang T, Dorian P. CCS Atrial Fibrillation Guideline Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: etiology and initial investigations. Can J Cardiol 2011;27:31-7.
6. Stiell IG, Macle L. CCS Atrial Fibrillation Guideline Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol 2011;27: 38-46.
7. Gillis AM, Verma A, Talajic, Nattel S, Dorian P. CCS Atrial Fibrillation Guideline Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and rhythm management. Can J Cardiol 2011;27:47-59.
8. Verma A, Macle L, Cox J, Skanes AC. CCS Atrial Fibrillation Guideline Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter. Can J Cardiol 2011;27:60-6.
9. Pagé P. CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: surgical therapy. Can J Cardiol 2011; 27:67-73.
10. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M. CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and atrial flutter. Can J Cardiol 2011;27:74-90.
11. Mitchell LB. CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol 2011;27:91-7.
12. Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol 2009;2:218-24.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results of the national registry of atrial fibrillation. JAMA 2001;285:2864-70. (Pubitemid 32537350)
14. Fung JWH, Cheuk-Man Y. The 2010 update of the ESC guidelines for the management of atrial fibrillation. Beyond the rate or rhythm strategy debate. Circulation Journal 2010;74:2538-41.
15. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S et al. Genderrelated differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. A report from the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 2007;49:572-7. (Pubitemid 46177436)
16. Hughes M, Lip GY. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008;99:295-304. (Pubitemid 351230959)
17. Stroke in AF working group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69:546-54.
18. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361: 1139-51.
19. Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-78.
20. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. An ACTIVE W Substudy. J Am Coll Cardiol 2007;50:2156-61. (Pubitemid 350123679)
21. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
22. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/ AHA/ESC guidelines for the mangement of atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation 2006;114:257-354.
23. Wyse DG,Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. (Pubitemid 35417773)
24. Van Gelder IC, Hagens VE, Bosker HA, Kingma H, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40. (Pubitemid 35417774)
25. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358:2667-77. (Pubitemid 351860859)
26. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-73.
27. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Perdersen C et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78.
28. Køber L, Torp-Pedersen C, McMurray JJ, Gøtzsche O, Lévy S, Crijns HJ et al. Increased mortality after dronedarone for severe heart failure. N Engl J Med 2008;358:2678-87. (Pubitemid 351860860)
29. Le Heuzey J-Y, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy J-M. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS Study. J Cardiovasc Electrophysiol 2010;21:597-605.
30. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation. Two systematic literature reviews and meta-analyses. Circ Arrhythmia Electrophysiol 2009; 2:349-61.